Pharmaceutical giant Pfizer has just declared mid-stage trial results for berobenatide, an experimental anti-obesity and diabetes drug designed to be taken just once a month
Their glucose-lowering mechanisms include glucose-dependent stimulation of insulin secretion, suppression of glucagon secretion, enhanced glucose uptake in skeletal muscle and adipose tissue, inhibition of hepatic gluconeogenesis, delayed gastric emptying, and appetite reduction (18)
Tirzepatide activates both GLP-1 and GIP (glucose-dependent insulinotropic peptide) receptors, triggering a dual metabolic response
There is some evidence that the peptide may also influence hair follicle growth
Appetite, reward, and impulse control are deeply intertwined with mental health, and GLP1 receptors are active in regions of the brain that influence mood, motivation, and behavior
One more thing Id like to point out with traditional medical advice regarding diet and diverticular disease is the notion that persons need to avoid nuts, seeds, corn, and popcorn